Clinical Evaluation |
---|
Noradrenalin analogue for evaluation of the neural crest |
Type of Imaging |
Scintigraphy |
Grade of Recommendation |
B (generally recommended) |
Level of Evidence |
well-established clinical and Nuclear Medicine recommendations |
Effective Dose |
13.0 µSv/MBq |
Bibliographic Reference |
Park, J.R., Bagatell, R., Cohn, S.L., Pearson, A.D., Villablanca, J.G., Berthold, F., Burchill, S., Boubaker, A., McHugh, K., Nuchtern, J.G., London,...
read more
Park, J.R., Bagatell, R., Cohn, S.L., Pearson, A.D., Villablanca, J.G., Berthold, F., Burchill, S., Boubaker, A., McHugh, K., Nuchtern, J.G., London, W.B., Seibel, N.L., Lindwasser, O.W., Maris, J.M., Brock, P., Schleiermacher, G., Ladenstein, R., Matthay, K.K., Valteau-Couanet, D. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017; https://doi.org/10.1200/JCO.2016.72.0177
read less
|
Guide to Nuclear Medicine |
Read the corresponding chapter |